实用医学杂志 ›› 2021, Vol. 37 ›› Issue (24): 3193-3196.doi: 10.3969/j.issn.1006⁃5725.2021.24.019

• 药物与临床 • 上一篇    下一篇

拉莫三嗪早期联合硝基安定治疗儿童失神癫痫的临床效果

林海生 戴津 程冰梅 江慧敏 肖华 王秀英 李嘉玲 陈文雄   

  1. 广州市妇女儿童医疗中心神经内科(广州 510120)

  • 出版日期:2021-12-25 发布日期:2021-12-25
  • 通讯作者: 陈文雄 E⁃mail:gzchcwx@126.com
  • 基金资助:
    广 东 省 医 学 科 学 技 术 研 究 基 金 项 目(编 号 :B2019030)

Clinical effect of early add ⁃ on nitrodiazepam to lamotrigine on absence epilepsy in children 

LIN Haish⁃ eng,DAI Jin,CHENG Bingmei,JIANG Huimin,XIAO Hua,WANG Xiuying,LI Jialing,CHEN Wenxiong.    

  1. Department of Neurology,Guangzhou Women and Children′s Medical Center,Guangzhou 510120,China 

  • Online:2021-12-25 Published:2021-12-25
  • Contact: CHEN Wenxiong E⁃mail:gzchcwx@126.com

摘要:

目的 对比观察拉莫三嗪(LTG)早期联合硝基安定(NZP)与丙戊酸钠(VPA)单药治疗儿童 失神癫痫的疗效及不良反应。方法 选取通过典型临床表现和视频脑电图确诊儿童失神癫痫患儿 52 例, 将其分为 VPA 26 例及 LTG+NZP 26 例,分别给予丙戊酸钠单药或拉莫三嗪早期联合硝基安定(服用 4 个月开始 1 个月内逐渐减停)治疗,随访 1 年,观察患者的发作控制情况以及不良反应。结果 VPA LTG + NZP 组患儿服药 1 个月时完全控制的分别为 12 例(48.0%)、10 例(41.7%);3 个月时分别为 14 56.0%)和 12 例(50.0%);6 个月时分别 15 例(60.0%)和 14 例(58.3%);12 个月时分别为 17 例(68.0%)和 16 例(66.7%),差异均无统计学意义(P > 0.05)。VPA 组和 LTG + NZP 组患儿治疗后 1 个月的总有效率分 别为 68.0% 66.7%;治疗后 3 个月总有效率分别为 72.0% 66.7%;治疗后 6 个月总有效率分别为 76.0% 75.0%;治疗后 12 个月分别为 84.0% 79.2%,差异无统计学意义(P > 0.05)。两组患儿不良反应发生率差 异无统计学意义(P > 0.05)。结论 拉莫三嗪早期联合硝基安定治疗儿童失神癫痫疗效与丙戊酸钠相 当;拉莫三嗪早期短时联合添加硝基安定治疗儿童失神癫痫,能兼顾疗效和起效速度。

关键词: 拉莫三嗪,  , 硝基安定,  , 丙戊酸钠,  , 失神癫痫,  , 儿童

Abstract:

Objective To compare the efficacy and side effects between early add ⁃ on Nitrodiazepam (NZP)to Lamotrigine(LTG)and sodium valproate(VPA)only on absence epilepsy in children. Methods The children with epilepsy diagnosed by typical clinical manifestations and video electroencephalogram were divided into VPA group(n = 26)and LTG+NZP group(n = 26). The children were treated with VPA or early add⁃on NZP to LTG respectively(NZP tailed off at 4th month within one month). The patients were followed up for 1 year to observe seizure control and adverse reactions of the patients. Results In VPA group and LTG+NZP group,12 cases (48.0%)and 10 cases(41.7%)were completely controlled at the first month;14 cases(56.0%)and 12 cases (50.0%)at the 3rd month;15 cases(60.0%)and 14 cases(58.3%),at the 6th month;and 17 cases(68.0%)and 16 cases(66.7%),at 12 months,indicating no statistical significance(P > 0.05). The total effective rate of VPA group and LTG + NZP group was 68.0% and 66.7% 1 month after treatment,72.0% and 66.7% 3 months after treatment,76.0% and 75.0% 6 months after treatment,and 84.0% and 79.2% 12 months after treatment,respec⁃ tively,showing no significant difference(P > 0.05). There was no significant difference in the incidence of adverse reactions between 2 groups(P > 0.05). Conclusion Early add⁃on NZP to LTG onchildren with absence epilepsy has nearly the same efficacy as sodium valproate. Early add ⁃ on NZP to LTG on children with absence epilepsy might take both curative effect and onset time into consideration.

Key words:

lamotrigine, nitrazepam, sodium valproate, absence epilepsy, children